Barclays’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$148K Sell
8,718
-15,986
-65% -$272K ﹤0.01% 3851
2025
Q4
$464K Buy
24,704
+412
+2% +$6.22K ﹤0.01% 3896
2025
Q3
$310K Sell
24,292
-5,143
-17% -$77.1K ﹤0.01% 4074
2025
Q2
$495K Buy
29,435
+6,852
+30% +$92.6K ﹤0.01% 3765
2025
Q1
$289K Sell
22,583
-10,766
-32% -$173K ﹤0.01% 3854
2024
Q4
$588K Sell
33,349
-17,982
-35% -$341K ﹤0.01% 3726
2024
Q3
$1.17M Buy
51,331
+20,331
+66% +$459K ﹤0.01% 3251
2024
Q2
$711K Sell
31,000
-6,420
-17% -$198K ﹤0.01% 2801
2024
Q1
$1.48M Buy
37,420
+3,672
+11% +$145K ﹤0.01% 2810
2023
Q4
$1.34M Buy
33,748
+23,264
+222% +$974K ﹤0.01% 3228
2023
Q3
$465K Sell
10,484
-175
-2% -$7.64K ﹤0.01% 2853
2023
Q2
$464K Sell
10,659
-6,656
-38% -$293K ﹤0.01% 2799
2023
Q1
$753K Buy
17,315
+7,739
+81% +$342K ﹤0.01% 2952
2022
Q4
$357K Buy
9,576
+2,696
+39% +$104K ﹤0.01% 3519
2022
Q3
$274K Sell
6,880
-122
-2% -$4.52K ﹤0.01% 3035
2022
Q2
$268K Buy
7,002
+2,578
+58% +$93.2K ﹤0.01% 3272
2022
Q1
$176K Sell
4,424
-12,549
-74% -$491K ﹤0.01% 3499
2021
Q4
$704K Buy
16,973
+7,447
+78% +$324K ﹤0.01% 3029
2021
Q3
$402K Buy
9,526
+5,181
+119% +$261K ﹤0.01% 3294
2021
Q2
$199K Sell
4,345
-9,328
-68% -$444K ﹤0.01% 3555
2021
Q1
$640K Buy
13,673
+4,276
+46% +$208K ﹤0.01% 3050
2020
Q4
$402K Sell
9,397
-1,898
-17% -$97.4K ﹤0.01% 3371
2020
Q3
$556K Sell
11,295
-200
-2% -$11.1K ﹤0.01% 3161
2020
Q2
$669K Buy
11,495
+5,938
+107% +$314K ﹤0.01% 3094
2020
Q1
$254K Sell
5,557
-6,486
-54% -$390K ﹤0.01% 4112
2019
Q4
$794K Buy
12,043
+5,449
+83% +$333K ﹤0.01% 3878
2019
Q3
$381K Sell
6,594
-1,160
-15% -$71.9K ﹤0.01% 4464
2019
Q2
$447K Buy
7,754
+3,810
+97% +$176K ﹤0.01% 4414
2019
Q1
$152K Buy
3,944
+3,809
+2,821% +$149K ﹤0.01% 5039
2018
Q4
$5K Sell
135
-4,240
-97% -$163K ﹤0.01% 6445
2018
Q3
$169K Buy
4,375
+3,395
+346% +$129K ﹤0.01% 5146
2018
Q2
$37K Sell
980
-2,372
-71% -$82.6K ﹤0.01% 5831
2018
Q1
$98K Buy
3,352
+1,673
+100% +$56.1K ﹤0.01% 5396
2017
Q4
$63K Buy
1,679
+1,459
+663% +$51.8K ﹤0.01% 5600
2017
Q3
$8K Buy
220
+214
+3,567% +$6.72K ﹤0.01% 6235
2017
Q2
$0 Sell
6
-570
-99% -$13.9K ﹤0.01% 6844
2017
Q1
$11K Buy
576
+287
+99% +$5.31K ﹤0.01% 6052
2016
Q4
$6K Buy
289
+56
+24% +$924 ﹤0.01% 6086
2016
Q3
$4K Buy
233
+205
+732% +$3.22K ﹤0.01% 6075
2016
Q2
$0 Buy
28
+23
+460% +$324 ﹤0.01% 6544
2016
Q1
$0 Buy
+5
New +$73 ﹤0.01% 6365
2015
Q4
Sell
-95
Closed -$1K 6401
2015
Q3
$1K Sell
95
-94
-50% -$1.25K ﹤0.01% 6570
2015
Q2
$3K Sell
189
-114
-38% -$1.61K ﹤0.01% 6690
2015
Q1
$4K Sell
303
-262
-46% -$3.7K ﹤0.01% 6691
2014
Q4
$7K Buy
565
+240
+74% +$3.53K ﹤0.01% 6886
2014
Q3
$4K Buy
325
+167
+106% +$2.3K ﹤0.01% 7246
2014
Q2
$2K Sell
158
-228
-59% -$3.43K ﹤0.01% 7403
2014
Q1
$6K Buy
386
+170
+79% +$2.85K ﹤0.01% 7140
2013
Q4
$3K Buy
216
+16
+8% +$281 ﹤0.01% 7279
2013
Q3
$4K Sell
200
-67
-25% -$1.15K ﹤0.01% 7040
2013
Q2
$5K Buy
+267
New +$4.26K ﹤0.01% 7352

Other funds holding NRC